Treatment of Helicobacter pylori

World Journal of Gastroenterology

Volumn 7, Issue 3, 2001, Pages 303-307

  Harris, A ^a  

^a KENT AND SUSSEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CLARITHROMYCIN; COLLOIDAL BISMUTH COMPOUND; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; RANITIDINE BISMUTH CITRATE; STOMACH SECRETION INHIBITOR; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; BREATH ANALYSIS; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DUODENUM BLEEDING; DUODENUM PERFORATION; DUODENUM ULCER; DYSPEPSIA; EPITHELIZATION; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LONG TERM CARE; NONHUMAN; OUTCOMES RESEARCH; PATIENT COMPLIANCE; RECURRENT DISEASE; RELAPSE; REVIEW; RISK FACTOR; STOMACH CANCER; STOMACH ULCER; SYMPTOMATOLOGY; TABLET; TASTE DISORDER; TREATMENT OUTCOME; ULCER HEALING;

EID: 0034960243     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i3.303     Document Type: Review

References (52)

1. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review
2. Incidence of duodenal ulcer healing after one week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori
3. The DU-MACH study: Eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy
4. Absence of dyspeptic symptoms as a test of H. pylori eradication
5. Treatment of Helicobacter pylori infection
6. Helicobacter pylori and complicated ulcer disease
7. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection
8. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori
9. Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance
10. Helicobacter pylori and non-steroidal anti-inflammatory drugs: Ulcers and bleeding ulcers
11. Helicobacter pylori infection and cancer
12. Functional gastroduodenal disorders
13. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
14. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
15. Eradication of Helicobacter pylori in functional dyspepsia: A randomised double blind placebo controlled trial with 12 months' follow up
16. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia
17. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia
18. Helicobacter pylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor?
19. Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management
20. Decreased prevalence of Helicobacter pylori infection in gastro-oesophageal reflux disease
21. Helicobacter pylori infection may be a factor of suppressing the development of reflux oesophagitis by inducing gastric hyposecretion
22. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease
23. H. pylori, GERD and the efficacy of omeprazole therapy
24. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
25. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of eosophageal and gastric cardia adenocarcinoma
26. CagA positive H. pylori and risk for developing gastro-oesophageal reflux
27. CagA positive H. pylori infection protects against GERD
28. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux oesophagitis
29. Effectiveness of anti-secretory therapy in preventing gastro-oesophageal reflux disease after successful treatment of Helicobacter pylori infection
30. High incidence of reflux oesophagitis after the eradication therapy of Helicobacter pylori: Impacts of role of hiatus hernia and corpus gastritis
31. No occurrence of reflux oesophagitis following Helicobacter pylori eradication in duodenal ulcer patients: A 5 year endoscopic follow up in south-east asian patients
32. Symptoms of gastro-oesophageal reflux in duodenal ulcer patients after treatment for Helicobacter pylori during a two year follow up
33. Does cure of Helicobacter pylori induce heartburn?
34. Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? A randomised double blind study
35. Symptomatic benefit 1 - 3 years post H. pylori eradication in ulcer patients: Impact of reflux disease
36. GERD symptoms preexist and do not appear after H. pylori eradication for duodenal ulcer
37. Gastric Helicobacter pylori infection accelerates healing of reflux oesophagitis during treatment with the proton pump inhibitor pantoprazole
38. Short course aid suppressive treatment for patients with functional dyspepsia: Results depend on Helicobacter pylori status
39. Atrophic gastritis and Helicobacter pylori infection in patients with reflux oesophagitis treated with omeprazole or fundoplication
40. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease
41. Treating Helicobacter pylori - The best is yet to come?
42. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong
43. One week triple therapy for Helicobacter pylori: A multicentre, comparative study
44. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
45. Short-term, low-dose triple therapy for eradication of Helicobacter pylori
46. Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials. The MACH1 Study
47. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: Results of a multicentre study in South-East Asia
48. One week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: The RBC-MACH study
49. Review article: Treatment of Helicobacter pylori infection with ranitidine bismuth citrate or proton pump inhibitor-based triple therapies
50. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: A double-blind, randomised trial
51. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication
52. Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth-citrate-based therapies